HUM vs PACB
Humana Inc (HUM) versus Pacific Biosciences of California (PACB) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Pacific Biosciences of California (PACB) is a medical devices company listed on US.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported PACB revenue for 2025-09-30 was $38.4M. Net income was -$38.0M. Revenue was down 3.3% from 2025-06-30 to 2025-09-30. PACB currently screens at market cap $387.1M.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. PACB currently screens at market cap $387.1M.
Not investment advice. Open the HUM and PACB stock pages for the full models.
Not investment advice.